Literature DB >> 3084988

Effects of corticotropin-releasing factor and growth hormone-releasing factor on sleep and activity in rats.

C L Ehlers, T K Reed, S J Henriksen.   

Abstract

The effects of corticotropin-releasing factor (CRF) and growth hormone-releasing factor (GRF) on electroencephalographic (EEG) and behavioral signs of sleep and wakefulness following intracerebroventricular (ICV) administration was investigated in adult male rats. Visual scoring of EEG records as well as spectral analysis revealed that CRF (0.0015-0.015 nmol) produced decreases in slow wave sleep concomitant with significant decreases in spectral power in lower frequencies (1-6 Hz) and increases in high frequencies (32-64 Hz). In contrast, GRF (2.0 nmol) produced increased EEG and behavioral signs of slow wave sleep associated with significant increases in spectral power in the low frequencies (1-2 Hz) and decreases in high frequencies (32-64 Hz). ICV administration of GRF was also found to produce decreases in locomotion when administered during the active part of the rats' circadian cycle. These EEG and behavioral findings seen following CRF and GRF are consistent with the behaviors frequently correlated with the known circadian timing of the release of corticosteroids and growth hormone during the sleep-waking cycle in rat and human.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3084988     DOI: 10.1159/000124489

Source DB:  PubMed          Journal:  Neuroendocrinology        ISSN: 0028-3835            Impact factor:   4.914


  44 in total

Review 1.  Alcohol use disorder and sleep disturbances: a feed-forward allostatic framework.

Authors:  George F Koob; Ian M Colrain
Journal:  Neuropsychopharmacology       Date:  2019-06-24       Impact factor: 7.853

2.  Increased brain cortical activity during parabolic flights has no influence on a motor tracking task.

Authors:  Stefan Schneider; Vera Brümmer; Andreas Mierau; Heather Carnahan; Adam Dubrowski; Heiko K Strüder
Journal:  Exp Brain Res       Date:  2007-11-01       Impact factor: 1.972

Review 3.  Neurobiological mechanisms for the regulation of mammalian sleep-wake behavior: reinterpretation of historical evidence and inclusion of contemporary cellular and molecular evidence.

Authors:  Subimal Datta; Robert Ross Maclean
Journal:  Neurosci Biobehav Rev       Date:  2007-03-12       Impact factor: 8.989

4.  Corticotropin releasing factor (CRF): studies in alcohol preferring and non-preferring rats.

Authors:  C L Ehlers; R I Chaplin; T L Wall; L Lumeng; T K Li; M J Owens; C B Nemeroff
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

5.  Deficiency of growth hormone-releasing hormone signaling is associated with sleep alterations in the dwarf rat.

Authors:  F Obál; J Fang; P Taishi; B Kacsóh; J Gardi; J M Krueger
Journal:  J Neurosci       Date:  2001-04-15       Impact factor: 6.167

6.  Contributions of neuronal prion protein on sleep recovery and stress response following sleep deprivation.

Authors:  Manuel Sánchez-Alavez; Bruno Conti; Gianluca Moroncini; José R Criado
Journal:  Brain Res       Date:  2007-05-22       Impact factor: 3.252

Review 7.  REM sleep abnormalities and psychiatry.

Authors:  J A Fleming
Journal:  J Psychiatry Neurosci       Date:  1994-11       Impact factor: 6.186

8.  Bretazenil modulates sleep EEG and nocturnal hormone secretion in normal men.

Authors:  J Guldner; L Trachsel; C Kratschmayr; B Rothe; F Holsboer; A Steiger
Journal:  Psychopharmacology (Berl)       Date:  1995-11       Impact factor: 4.530

9.  Growth hormone-releasing hormone activates sleep regulatory neurons of the rat preoptic hypothalamus.

Authors:  Zoltan Peterfi; Dennis McGinty; Erzsebet Sarai; Ronald Szymusiak
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-11-04       Impact factor: 3.619

10.  Conditional corticotropin-releasing hormone overexpression in the mouse forebrain enhances rapid eye movement sleep.

Authors:  M Kimura; P Müller-Preuss; A Lu; E Wiesner; C Flachskamm; W Wurst; F Holsboer; J M Deussing
Journal:  Mol Psychiatry       Date:  2009-05-19       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.